TECH OUTLOOK 6NOVEMBER - 2020TECH OUTLOOKEditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comPharmaceutical outsourcing has become a huge industry and acts as an essential driver behind many of the essential drugs brought to market at the moment. The primary reason for the increase in pharmaceutical companies' outsourcing are the complex challenges related to drug development. The average cost of drug development can extent to billions of dollars and requires an average of ten years to deliver a new drug to the market. Many drugs were unable to be effective clinically and have never reached the market. Due to this uncertainty, pharmaceutical companies are unwilling to make use of their onsite resources for research and development. However, outsourcing facilitates organizations in this sector to curtail both their operational and manufacturing costs and thereby reduces financial risk.Pharmaceutical companies at present are increasingly outsourcing to stay competitive and flexible in a world of technological advancements. Outsourcing benefits companies to save on resource cost, infrastructure cost, and other overhead expenditures. Even though the reduction of expenditure remains the essential reason for outsourcing several functions across the industry, in several big pharma firms there has been a colossal shift in outsourcing motivations. Innovations in pharmaceutical development depend on an approach that focuses on areas where unfulfilled requirements exist. It is also imperative for pharmaceutical companies to notice that there is a growing shortage of successful drugs. Outsourcing research and development activities and focusing on implementing the required strategies that will help meet increasing requirements can ensure higher ROI and significant cost savings. The increasing pressure on pharma companies to develop their return on investments will drive the pharma outsourcing industry even further. Besides, it is observed that pharma majors are preferring vendors with an end-to-end suite of services and global expertise to help make the processes smarter and seamless.As the metamorphosis in drug development continues, we present the Top 10 Pharma Outsourcing Consulting/Services Companies - 2020 that are catalyzing their transformation in the industry. This edition also features insightful articles that emphasize on the manifold benefits of using the latest technologies for better results. Let us know your thoughts!Elevating Efficiency with OutsourcingCopyright © 2020 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.NOVEMBER - 03 - 2020, Vol 06 - Issue 15 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerRonald DonovanAsher BlakeEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Contact Us:Phone:510.556.2402, Fax:510-894-8405TECH OUTLOOK
< Page 5 | Page 7 >